{
  "denotations": [
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 116,
        "end": 129
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 183,
        "end": 198
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 206,
        "end": 211
      }
    },
    {
      "id": "T12",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 240,
        "end": 258
      }
    },
    {
      "id": "T13",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 298,
        "end": 312
      }
    },
    {
      "id": "T14",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 326,
        "end": 329
      }
    },
    {
      "id": "T15",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 66,
        "end": 100
      }
    },
    {
      "id": "T17",
      "obj": "Chemical",
      "span": {
        "begin": 392,
        "end": 399
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "12052467_7",
  "text": "This review aims to give an overview of the known polymorphisms ( Cholesteryl Ester Transfer Protein polymorphism , Stromelysin-1 polymorphism , -455G/A and TaqI polymorphisms of the beta-fibrinogen gene , apoE4 , Asp(9)Asn mutation in the lipoprotein lipase gene , the -514 CT polymorphism in the hepatic lipase gene and the ACE deletion type gene ) that have an influence on the effects of statins in the general population ."
}
